Infection with SARS-CoV-2 leads to COVID-19, the severity of which is partly due to host immune responses, including the release of proinflammatory cytokines, such as interleukin (IL)-6, IL-18 and tumor necrosis factor (TNF), with serious biological and clinical consequences [21,22]. This evidence concerns the gene IL6 and infection.